Orion Pharma Limited (DSE: ORIONPHARM)
Health Care · Pharmaceuticals · BD
Tk26.20
-9.66% today · -20.1% 1Y
Orion Pharma Limited (DSE: ORIONPHARM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $49.78M.
Over the last twelve months the share price has lost 20.1%, trading between 22.90 and 35.60.
Tweenvest scores Orion Pharma Limited across four factors: quality 54/100, value 55/100, growth 0/100. Its strongest factor is value.
ORIONPHARM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.78M
- Revenue (TTM)
- $24.55M
- P/E
- —
- EPS
- -2.54
- Dividend yield
- —
- Beta (5Y)
- -0.45
- 52-week high
- Tk35.60
- 52-week low
- Tk22.90
- Avg volume (3M)
- —
- Shares outstanding
- 234.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Central Pharmaceutical Joint Stock Company No3HNX: DP3 | $50.83M | ₫61,200.00 | +0.99% |
| Sinsin Pharmaceutical Co., LtdKOSDAQ: A002800 | $50.44M | ₩4,470.00 | +0.34% |
| Sareum Holdings plcAIM: SAR | $50.33M | £0.28 | -8.33% |
| Infinium Pharmachem LimitedNSEI: INFINIUM | $50.32M | Rs312.50 | -0.56% |
| Neurizon Therapeutics LimitedASX: NUZ | $49.76M | AU$0.09 | +15.00% |
| Labiana Health, S.A.BME: LAB | $49.71M | €5.25 | -1.87% |
| China NT Pharma Group Company LimitedSEHK: 1011 | $49.58M | HK$0.41 | +6.49% |
| Anya Biopharm Inc.TPEX: 7776 | $49.22M | NT$32.05 | -6.56% |
Figures last refreshed Oct 11, 2026.